申请人:——
公开号:US20040127517A1
公开(公告)日:2004-07-01
The present invention relates to compounds of formula (I):
1
in which X represents N or CH; R
1
represents a hydrogen or halogen atom or a CF
3
group; R
2
and R
3
independently represent a hydrogen atom or a methyl group; n is 0 or 1; A represents a condensed heterocyclic group of formula (w)
2
where W completes an aromatic or saturated 6-membered ring system comprising one or two nitrogen atoms or else an aromatic or saturated 5-membered ring system comprising a nitrogen, oxygen or sulfur atom which are optionally substituted, and to their N-oxides and to their salts or solvates, to the pharmaceutical compositions and the medicaments comprising them and to a process for their preparation.
本发明涉及以下式(I)的化合物:
其中X代表N或CH;R1代表氢或卤素原子或CF3基团;R2和R3独立地代表氢原子或甲基基团;n为0或1;A代表具有以下式(w)2的缩合杂环基团,其中W完成一个含有一个或两个氮原子的芳香或饱和的6元环系统,或者一个含有一个氮、氧或硫原子的芳香或饱和的5元环系统,这些原子可以被取代,以及它们的N-氧化物、盐或溶剂化合物,以及包含它们的药物组合物和药物,以及它们的制备方法。